Status | Study |
Recruiting |
Study Name: Super Chinese Nephrotic Syndrome Registration System (SUCCESS) Condition: Nephrotic Syndrome Date: 2016-12-21 Interventions: Other: No intervention Registration of all NS patients in the First Affiliated Hospital of Sun Yat-sen U |
Active, not recruiting |
Study Name: Safety and Efficacy of Combination Acthar Gel and Tacrolimus in the Treatment of Steroid Resistant Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2016-03-30 Interventions: Drug: Acthar Gel and Tacrolimus Combination therapy with Acthar Gel and Tacrolimus (0.5-3.0 mg BID) foll |
Completed |
Study Name: IL-2 for Multi Drug Resistant Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2015-05-13 Interventions: Drug: Proleukin® Other Name: IL-2 |
Completed |
Study Name: Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Dependent Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2015-05-06 Interventions: Drug: Tacrolimus Oral Tacrolim |
Recruiting |
Study Name: Ofatumumab in Children With Drug Resistant Idiopathic Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2015-03-06 Interventions: Drug: Ofatumumab Ofatumumab 15 |
Recruiting |
Study Name: Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Resistant Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2015-03-03 Interventions: Drug: Rituximab Two to four ri |
Recruiting |
Study Name: Glucocorticoid in Treatment of Adult Idiopathic Nephrotic Syndrome:a Prospective Observational Study Condition: Nephrotic Syndrome,Idiopathic Date: 2014-10-20 Interventions: Drug: prednisone Full-dose induction period: Prednisone 1mg/kg.day, maximum 60mg/day, orally, divided in |
Recruiting |
Study Name: A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2014-10-02 Interventions: Drug: Mizoribine (MZR) Other N |
Completed |
Study Name: Assessment of the Educational Experiences for Patients Newly Diagnosed With Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2014-05-30 |
Recruiting |
Study Name: Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2013-12-12 Interventions: Drug: ACTH Patients will receive ACTH twice weekly for 6 months, with a 50% dose reduction allowed for s |